Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says

Business Insider - 2 Jun 2024 06:02
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a research note.
Full Article at Business Insider

More Business News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard